PRF PARKINSON’S DISEASE: TREATMENTS OF THE FUTURE
Tampa Westshore Marriott Tampa, Florida
Monday, March 26, 2012
Program chair, Dr. Juan Sanchez-Ramos
The Parkinson Research Foundation will be presenting a conference to provide Parkinson’s disease patients and caregivers in Southwest Florida with an opportunity to learn about the latest drugs and treatments for Parkinson’s disease that will enhance their lives. A secondary objective is to provide a forum for patients and caregivers to share their concerns and successes with Parkinson’s experts and other local patients. Dr. Juan Sanchez- Ramos received his Ph.D in Pharmacology and Physiology from the University of Chicago, completed his Medical Degree from the University of Illinois, College of Medicine. He completed his residency in Neurology at the Michael Reese Hospital, University of Chicago and his fellowship at the University of Miami. Currently, Dr. Sanchez-Ramos is a professor of Neurology at the University of South Florida in Tampa, Florida and holds the Helen Ellis endowed Chair for Parkinson’s disease research. He’s the Director of Stem Cell Research, Center for Aging and Brain Repair, in Tampa, Fl. Dr. Sanchez-Ramos’s current research projects include movement disorders, the neurobiology of adult tissue stem cells, and DNA repair mechanisms in aging neurons. At the conference, he will be talking about Non-motor Symptoms of Parkinson’s disease and Treatments of the Future.
This 1-day program will have general session presentations throughout the day, exhibition sessions during the sponsored breaks and a question and answer session at the end of the day for full interaction and discussion between participants and speakers.
For more information about PRF or to register for this March 26, 2012 conference, please contact Ms. Rosa Seminario at email@example.com or call (800) 869-1551 ext. 0. Thank you for your interest and support.
The Parkinson Research Foundation is a nonprofit health organization providing Parkinson's disease research, information and advocacy. The mission of PRF is to help cure Parkinson's disease and to improve the lives of all people affected by the disease. To fulfill this mission, the Parkinson Research Foundation will fund research, publish scientific findings, provide funding for information and other services to people with Parkinson's disease, their families, caregivers, health care professionals and the public. PRF also expects to be actively involved in advocating for scientific research and for the rights of people with Parkinson's disease.
The money raised by PRF funds research, information programs, and advocacy and awareness efforts that will support the over one million people with Parkinson's disease in communities across America.
Parkinson Research Foundation
8586 Potter Park Drive
Sarasota, FL 34238
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PRF PARKINSON’S DISEASE: TREATMENTS OF THE FUTURE here
News-ID: 212489 • Views: 1001
More Releases from Parkinson Research Foundation
PARKINSON RESEARCH FOUNDATION Announces Director of Patient Programs, Services a …
The Parkinson Research Foundation is pleased to announce that Marilyn Tait has joined the foundation as the Director of Patient Programs, Services and Advocacy. Tait, is a graduate of Thomas Jefferson University School of Nursing in Philadelphia, Pennsylvania. Tait has forty years experience in healthcare marketing and program development. After specializing in oncology for 30 years, Tait embarked on her new career at a time in her life when
Parkinson Research Foundation PRF Encourages Patients To Attend Upcoming Cruise …
PRF is hosting its fourth educational cruise from January 8 – 15, 2012. Cruisers will set sail out of Port Canaveral, Florida on Royal Caribbean’s Freedom of the Seas to embark on a seven-night Western Caribbean adventure. The Parkinson Research Foundation (PRF) developed an educational cruise program to help Parkinson patients, caregivers and their loved ones learn about Parkinson’s and connect with fellow patients from across the world. Each PRF
PARKINSON RESEARCH FOUNDATION’S (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU …
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field. After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRF’s ventured to the Western Caribbean on its most
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRF’s focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease. The Foundation’s educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affected
More Releases for Park
Systech Illinois acquired by Union Park Capital
We are pleased to announce that Industrial Physics, Inc., a Boston-based test and measurement manufacturer and portfolio company of Union Park Capital have acquired Systech Illinois. Systech Illinois' application and technology expertise provides efficient gas analysis solutions in many industry sectors worldwide will be joined with TM Electronics in the Industrial Technology Group, as an independent operating entity under Industrial Physics. By combining resources the new formation will bring
Lothbury completes new retail park in Salisbury
Lothbury Investment Management (LIM), on behalf of Lothbury Property Trust (LPT), has completed the construction of four new retail units in Salisbury. The extension of an existing asset has created 55,000 sq ft of new retail warehouse space, all of which was pre-let and has recently opened for trade. Formerly known as Dolphin Industrial Estate, the site was identified by the LIM team as an opportunity to add value through development
Ascendas Park Square Opens at International Tech Park Bangalore (ITPB)
Ascendas Services (India) Pvt Ltd today held the official opening ceremony of the Ascendas Park Square Mall located in International Tech Park Bangalore (“ITPB”). The official opening of Ascendas Park Square was marked by the inauguration ceremony graced by Ms. Karen Tan, High Commissioner of the Republic of Singapore. The celebrations will extend through the upcoming holiday season, featuring month-long festivities in the mall including concerts and weekend events. Ascendas
Forest Park Medical Center at Southlake
Forest Park Medical Center is pleased to announce the start of construction of their physician-owned hospital in Southlake on the south side of S.H. 114 just east of N. White Chapel Boulevard. The project will include an acute care hospital of approximately 140,000 square feet, a medical office building of approximately 80,000 square feet, and a parking garage. This represents the first phase of development of what will ultimately be
Solar Park Wisselsing (6.3 MW)
Solea proudly announces the commissioning of its Solar Park Wisselsing in the municipality of Osterhofen in October 2010. The Solar Park has an installed nominal capacity of approx. 6.3 MW and is one of the largest solar installations in the entire region. The Solar Park remains governed by the German FIT Law 2009. Employer and operator of the Solar Park is a project company wholly owned by Solea AG. The
Novalung now in “Future Park”
The innovative medical device company moves into new headquarters in Southern Germany On October 27th the new head office of Novalung GmbH was officially opened. During a short celebration CEO Dr. Georg Matheis and COO Hannes Wetscher inaugurated the new offices located in the newly constructed technology park “Zukunftspark” (Future Park) in Heilbronn, approximately halfway between Stuttgart and Frankfurt in the South of Germany. ”Our innovative solutions for lung failure are gaining